EBLN1: A Potential Drug Target Or Biomarker for Diseases (G340900)

Target Name: EBLN1

NCBI ID: G340900

EBLN1

EBLN1: A Potential Drug Target Or Biomarker for Diseases

EBLN1 (EBLN1_HUMAN), a gene that encodes a protein known as EBLN1, has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The EBLN1 gene is located on chromosome 12q34 and encodes a protein that is expressed in various tissues and organs, including the brain, spinal cord, heart, kidneys, and intestines. The protein is known to play a role in the development and maintenance of blood vessels, and is also involved in the regulation of ion channels and neurotransmitter release.

Studies have suggested that EBLN1 may be involved in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, EBLN1 has been shown to be overexpressed in various types of cancer, and may contribute to the development of cancer stem cells. Additionally, EBLN1 has been implicated in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, and may be a potential drug target for these conditions.

In addition to its potential role in disease, EBLN1 has also been shown to be a potential biomarker for several diseases. For example, EBLN1 has been used as a biomarker for cancer, as it has been shown to be upregulated in the brains of patients with various types of cancer. Additionally, EBLN1 has been used as a biomarker for neurodegenerative diseases, as it has been shown to be decreased in the brains of patients with Alzheimer's disease and other forms of neurodegenerative disease.

Despite the potential benefits of EBLN1 as a drug target or biomarker, further research is needed to fully understand its role in disease and to develop effective treatments. Currently, there are no approved drugs that specifically target EBLN1. Researchers are also working to develop new techniques for studying EBLN1, such as RNA interference and protein arrays, to better understand its role in disease.

In conclusion, EBLN1 is a gene that has the potential to be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand its role in disease and to develop effective treatments.

Protein Name: Endogenous Bornavirus Like Nucleoprotein 1

Functions: May act as an RNA-binding protein. Highly homologous to the bornavirus nucleocapsid N protein that binds viral RNA and oligomerizes (By similarity)

The "EBLN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EBLN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets